A potential regulatory function of anti-Id is through neutralization of pathogenic autoantibodies, a mechanism that may explain the beneficial use of Intravenous Immunoglobulin in treatment of autoimmune diseases [19]. This evidence concerns the gene ID1 and autoimmune disease.